Item 1.01 Entry into a Material Definitive Agreement.
On
As previously reported, under the Sales Agreement, the Company may offer and
sell its Shares (the "Offering"), from time to time, at its option, through or
to A.G.P., in an "at the market offering" as defined in Rule 415(a)(4)
promulgated under the Securities Act of 1933, as amended, or if specified by the
Company, by any other method permitted by law. Shares that have been or that may
be offered and sold under the Sales Agreement have been and will be issued and
sold pursuant to the Company's Registration Statement on Form S-3 (File No.
333-223130), filed with the
The Company has been using, and currently intends to continue to use, any net proceeds from the Offering for research and development, sales and marketing, working capital and other general corporate purposes, and any other purposes that may be stated in any future prospectus supplement.
This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares, nor shall there be any offer, solicitation or sale of the Shares in any state or country in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or country.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Description 1.1 Sales Agreement, datedJuly 28, 2020 , by and betweenInspireMD, Inc. and A.G.P./Alliance Global Partners (incorporated by reference to Exhibit 1,1 to the Company's Current Report on Form 8-K filed with theSEC onJuly 28, 2020 ). -2-
© Edgar Online, source